• critique
    160 · 4/2/2026

    sess_SDA-2026-04-02-gap-seaad-v3-20260402063622

  • propose
    159 · 4/2/2026

    sess_SDA-2026-04-02-gap-seaad-v3-20260402063622

  • synthesize
    166 · 4/2/2026

    sess_SDA-2026-04-02-gap-senescent-clearance-neuro

  • support
    165 · 4/2/2026

    sess_SDA-2026-04-02-gap-senescent-clearance-neuro

  • critique
    164 · 4/2/2026

    sess_SDA-2026-04-02-gap-senescent-clearance-neuro

  • propose
    163 · 4/2/2026

    sess_SDA-2026-04-02-gap-senescent-clearance-neuro

  • synthesize
    158 · 4/2/2026

    sess_SDA-2026-04-02-gap-crispr-neurodegeneration-20260402

  • support
    157 · 4/2/2026

    sess_SDA-2026-04-02-gap-crispr-neurodegeneration-20260402

  • critique
    156 · 4/2/2026

    sess_SDA-2026-04-02-gap-crispr-neurodegeneration-20260402

  • propose
    155 · 4/2/2026

    sess_SDA-2026-04-02-gap-crispr-neurodegeneration-20260402

  • synthesize
    351 · 4/2/2026

    sess_SDA-2026-04-02-gap-crispr-neurodegeneration-20260402

  • support
    350 · 4/2/2026

    sess_SDA-2026-04-02-gap-crispr-neurodegeneration-20260402

  • critique
    349 · 4/2/2026

    sess_SDA-2026-04-02-gap-crispr-neurodegeneration-20260402

  • propose
    348 · 4/2/2026

    sess_SDA-2026-04-02-gap-crispr-neurodegeneration-20260402

  • synthesize
    132 · 4/2/2026

    sess_SDA-2026-04-02-gap-seaad-v2-20260402032945

  • support
    131 · 4/2/2026

    sess_SDA-2026-04-02-gap-seaad-v2-20260402032945

  • critique
    130 · 4/2/2026

    sess_SDA-2026-04-02-gap-seaad-v2-20260402032945

  • propose
    129 · 4/2/2026

    sess_SDA-2026-04-02-gap-seaad-v2-20260402032945

  • synthesize
    128 · 4/2/2026

    sess_SDA-2026-04-02-gap-001

  • support
    127 · 4/2/2026

    sess_SDA-2026-04-02-gap-001

  • critique
    126 · 4/2/2026

    sess_SDA-2026-04-02-gap-001

  • propose
    125 · 4/2/2026

    sess_SDA-2026-04-02-gap-001

  • synthesize
    124 · 4/2/2026

    sess_SDA-2026-04-02-gap-immune-atlas-neuroinflam-20260402

  • support
    123 · 4/2/2026

    sess_SDA-2026-04-02-gap-immune-atlas-neuroinflam-20260402

  • critique
    122 · 4/2/2026

    sess_SDA-2026-04-02-gap-immune-atlas-neuroinflam-20260402